PUBLISHER: The Business Research Company | PRODUCT CODE: 1946734
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946734
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
Tariffs are impacting the pediatric heart valve repair and replacement market by increasing import and component costs for precision metals, biologic valve materials, catheter devices, and surgical hardware used across repair systems, mechanical valves, bioprosthetic valves, and TAVI devices, thereby raising manufacturing and procurement expenses for hospitals and cardiac catheterization labs. The impact is most pronounced in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing for pediatric cardiac implants and catheter-based systems, particularly within congenital heart defect and atresia treatment segments. These higher landed costs have slowed capital purchasing cycles in price-sensitive facilities; however, tariffs are also encouraging localized production partnerships, regional component sourcing, and selective innovation in cost-optimized pediatric valve technologies.
The pediatric heart valve repair and replacement market research report is one of a series of new reports from The Business Research Company that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.47 billion in 2025 to $3.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to rising burden of congenital heart defects in neonatal and pediatric populations, growing availability of surgical heart valve repair techniques, increasing pediatric cardiac surgeries in hospital-based cath labs, early clinical adoption of mechanical and bioprosthetic pediatric valves, expansion of specialized pediatric cardiology and cardiac surgery centers.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter pediatric valve interventions, rising focus on long-term valve performance and reintervention reduction, growing treatment volumes across atresia and arrhythmia indications, expanding access to pediatric cardiac care in emerging regions, increasing investment in pediatric-specific heart valve design and durability research. Major trends in the forecast period include rising adoption of pediatric heart valve repair procedures for congenital cardiac disorders, increasing utilization of mechanical and bioprosthetic valves in pediatric valve replacement, growing preference for minimally invasive and catheter-based valve repair techniques, expansion of tavi-based interventions in complex pediatric valve conditions, increasing clinical focus on long-term durability and growth-compatible pediatric valve solutions.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births-approximately 40,000 infants-each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company's transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2025. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Heart Valve Repair And Replacement Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pediatric heart valve repair and replacement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric heart valve repair and replacement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric heart valve repair and replacement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.